Target intelligence / Profile preview

Bacterial ferroptosis

Molecular classification
Other
01

Overview

Bacterial ferroptosis refers to an iron-dependent, regulated form of cell death in bacteria that shares key biochemical hallmarks with eukaryotic ferroptosis, specifically lipid peroxidation and reactive oxygen species (ROS) accumulation [1, 13]. While bacteria lack some of the complex pathways found in eukaryotic cells, specific species such as Pseudomonas aeruginosa and Vibrio vulnificus exhibit ferroptosis-like responses triggered by iron overload or the activity of lipoxygenases like pLoxA [1, 9, 13]. This pathway is typically antagonized by antioxidant systems involving glutathione and iron-regulatory proteins such as the Ferric Uptake Regulator (Fur) [1, 13]. Inducing bacterial ferroptosis is being explored as a novel antimicrobial strategy to combat multidrug-resistant pathogens by bypassing traditional resistance mechanisms associated with cell wall or protein synthesis inhibitors [1, 2]. However, the therapeutic application is challenged by the need for high specificity to avoid inducing ferroptosis in host tissues and the potential for toxicity associated with altering systemic iron levels [1, 6]. Current research is focused on characterizing the unique molecular mediators in prokaryotes to develop selective ferroptosis inducers as next-generation antibiotics [1, 13].

Other names
Ferroptosis-like cell death in bacteriaBacterial iron-dependent cell deathPro-oxidative bacterial deathBacterial iron death
02

Mechanism of action

Induction of iron-dependent lipid peroxidation and accumulation of reactive oxygen species leading to irreversible damage of the bacterial cell membrane and subsequent cell death [1, 13].

03

Biological functions

Cell deathOxidative stress responseIron homeostasisLipid metabolismReactive oxygen species (ROS) metabolism
04

Disease associations

InfectionBacterial drug resistanceTuberculosisCystic fibrosis
05

Safety considerations

Off-target induction of ferroptosis in host human cellsSystemic iron metabolism disruptionPotential toxicity to the commensal microbiome
06

Interacting drugs

Ferrostatin-1

5 more in the full profile.

07

Biomarkers

Malondialdehyde (MDA)4-Hydroxynonenal (4-HNE)Intracellular labile iron (Fe2+)Glutathione (GSH) depletionReactive oxygen species (ROS) levels

Beyond the preview

Go deeper on Bacterial ferroptosis.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial ferroptosis.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call